Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	11.48B -53.3%
Revenue (ttm)	1.12B +37.4%
Net Income	151.92M +67.7%
EPS	2.28 +65.6%
Shares Out	65.86M
PE Ratio	76.48
Forward PE	39.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	111,256
Average Volume	309,238
Open	175.00
Previous Close	174.30
Day's Range	174.30 - 180.10
52-Week Range	168.50 - 402.00
Beta	0.39
RSI	41.62
Earnings Date	Feb 24, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 143
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.